Garde Capital, Inc. Astrazeneca PLC Transaction History

Garde Capital, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 27, 2022	SELL	$55.72 - $67.12 $160,585 - $193,439	-2,882 Closed	0 $0
Q4 2021 Feb 25, 2022	BUY	$54.02 - $63.83 $43,270 - $51,127	801 Added 38.49%	2,882 $168,000
Q3 2021 Nov 17, 2021	BUY	$55.56 - $60.79 $833 - $911	15 Added 0.73%	2,081 $125,000
Q1 2021 May 24, 2021	BUY	$47.16 - $54.44 $424 - $489	9 Added 0.44%	2,066 $103,000
Q4 2020 Feb 26, 2021	BUY	$48.52 - $58.02 $99,805 - $119,347	2,057 New	2,057 $102,000

1,334

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $220B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Garde Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Garde Capital, Inc. with notifications on news.